We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Deferasirox

Australian Public Assessment Report

AusPAR

AusPAR: Deferasirox [PDF, 577.79 KB]

AusPAR: Deferasirox [Word, 428.44 KB]

Attachment: Product Information: Deferasirox [PDF, 251.03 KB]

Attachment: Product Information: Deferasirox [Word, 73.8 KB]

Attachment: Extract from Clinical Evaluation Report: Deferasirox [PDF, 513.89 KB]

Attachment: Extract from Clinical Evaluation Report: Deferasirox [Word, 409.6 KB]

Device/Product Name

Exjade

Active ingredients

Deferasirox

AusPAR Date

6 March 2014

Published

3 April 2014

Submission Number

PM-2012-03063-1-4

Submission Type

Extension of indications

Decision

Approved